R. Hathout

Design, synthesis, and nanomedicine based delivery of benzimidazole derivatives with promising antiproliferative activity.

These findings highlight benzimidazole derivatives, particularly 16a and 17b and their nanoparticle formulations, as promising anticancer candidates, driven primarily by strong cellular potency and favorable safety, substantiating their potential as lead candidates for further optimization and therapeutic development.